Sarah DeFeo
Technik-/Wissenschafts-/F&E-Leiter bei Ovarian Cancer Research Fund, Inc.
Profil
Sarah DeFeo is currently the Vice President-Scientific Affairs & Programs at Ovarian Cancer Research Fund, Inc. She previously worked as a Principal at Icahn School of Medicine at Mount Sinai.
Ms. DeFeo holds a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Vassar College.
Aktive Positionen von Sarah DeFeo
| Unternehmen | Position | Beginn |
|---|---|---|
Ovarian Cancer Research Fund, Inc.
 Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2010 |
Ehemalige bekannte Positionen von Sarah DeFeo
| Unternehmen | Position | Ende |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Ausbildung von Sarah DeFeo
| Vassar College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Ovarian Cancer Research Fund, Inc.
Ovarian Cancer Research Fund, Inc. Investment ManagersFinance Ovarian Cancer Research Fund, Inc. offers funds to find a method of early detection and ultimately a cure for ovarian cancer. It provides education and support to families living through an ovarian cancer diagnosis, OCRF funds the research and programs needed to ensure hope for a future without ovarian cancer. The company was founded by Ann Schreiber in 1994 and is headquartered in New York, NY. | Finance |
